New horizons for HCC treatment
HCC treatments are evolving and can change patient care. Want to discover more? Watch our experts discuss these evolutions.
E22001186
Dr. Irene Bargelini
Pisa University Hospital - Pisa, Italy
Prof. Thierry de Baere
Institut Gustave Roussy - Villejuif, France
Dr. Rafael Duran
Lausanne University Hospital - Lausanne, Switzerland
Moderator: Dr. Irene Bargelini
- HCC management guidelines evolution - Dr. Irene Bargelini (Pisa, Italy)
- INSPIRE: INitiative on SuPerselectIve cTACE Results- Prof. Thierry de Baere (Villejuif, France)
- Immunotherapy and cTACE combination an effective solution? Dr. Rafael Duran (Lausanne, Switzerland)